Kadant's empty dividend headline is hiding a compounder trading at 31x earnings

Kadant announced another quarterly cash dividend this week: $0.36 a share, payable November 12. On its own, that press release is nearly content-free — the board already raised the rate to $0.36 back in March, so this is a repeat, not an increase.

But the announcement is worth pausing over for what it does not say. For an investor hunting income, Kadant is a disappointment dressed up as a dividend stock. Its yield is roughly half a percent. A $10,000 position returns about $50 a year in cash.

That tiny yield is the tell. Kadant is not an income stock; it is a dividend-growth compounder sitting at the extreme end of what I call the equity yield curve — very low yield, very high growth. The dividend's job here is not to pay you now. It is to signal durability.

What the dividend is really saying

Here is why that signal carries weight. The dividend has grown in each of the last 12 years. The payout consumes only about 15% of earnings, and the entire annual dividend drains roughly one dollar out of every ten of free cash flow — a cost so small the company could fund it out of spare change.

That cushion matters because it tells you the payout is not the risk. Kadant shares the traits of the real-economy businesses I look for: it sells engineered equipment and aftermarket parts to process industries — paper, pulp, recycling, wood-based materials — where uptime, fiber yield, and energy efficiency directly shape a plant's economics. Parts and consumables represent 68% of revenue and 72% of bookings, a recurring, annuity-like base. A paper mill does not casually swap its parts supplier; that is pricing power in installed-base form.

So the dividend is a durability badge, not an income stream. Management even signals as much with its capital allocation: in May the board authorized up to $50 million of buybacks — roughly three times the annual dividend. Kadant returns capital primarily through growth and repurchases, with the dividend as the smaller, steadier engine.

The funded growth

That recurring base is funding real, if uneven, growth. In the second quarter revenue rose 23% to a record $312.9 million, with about 8% of that organic; adjusted earnings per share hit a record $3.42; free cash flow came in at $42.6 million. Management raised its full-year revenue outlook to $1.19–$1.21 billion. The installed base is throwing off cash, and that cash is being reinvested.

The number that matters is bookings

But the fine print is less clean than the record headline. Gross margin fell 210 basis points to 43.8% on unfavorable product mix and the lower margin profile of recent acquisitions. And here is the leading indicator I actually watch: bookings — which reveal where revenue is headed, not where it has been — rose 16% on paper but fell 1% organically, with the industrial processing unit's organic bookings down on customer caution and extended approval cycles.

That is the cyclical tell. The market is meanwhile paying a premium for the growth: about 31x trailing earnings and roughly 34x forward. The stock has fallen about 14% over the past month, an outcome, not a cause — but it tells you investors are already second-guessing whether the growth is worth the multiple.

Alongside the dividend, the company also announced a leadership transition: Jeffrey Powell, CEO since 2019, hands off to Michael Colwell, who becomes president and COO in October and CEO in early January. A planned handover at a company whose dividend is covered ten times over is unlikely to threaten the payout; it is the sort of thing worth noting, not fearing.

The case, reduced

My read is this: Kadant is a quality real-economy compounder whose dividend is evidence of durability, not a source of income. It belongs in the income-growth sleeve only for someone with a long horizon who accepts that a sub-1% yield at a premium valuation leaves little margin for error.

The dividend will almost certainly survive; the real question is whether the share price does. You are not buying the yield — you are buying the streak's ability to continue, and that depends on pricing power converting into booked orders. If the cautious customers and stalled organic bookings persist, the premium multiple has room to compress, and a perfectly safe dividend will not protect the price. That, not the quarterly check, is what this headline is really asking you to weigh.